Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Risk for Ventricular Fibrillation in Peripartum Cardiomyopathy with Severely Reduced Left Ventricular Function—Value of the Wearable Cardioverter/Defibrillator

Open access
Duncker, David, Haghikia, Arash, König, Thorben, Hohmann, Stephan, Gutleben, Klaus-Jürgen, Westenfeld, Ralf, Oswald, Hanno, Klein, Helmut, Bauersachs, Johann, Hilfiker-Kleiner, Denise, Veltmann, Christian·2014·European Journal of Heart Failure

Abstract

Aims: The true incidence of life-threatening ventricular tachyarrhythmic events and the risk of sudden cardiac death in the early stage of peripartum cardiomyopathy (PPCM) are still unknown. We aimed to assess the usefulness of the wearable cardioverter/defibrillator (WCD) to bridge a potential risk for life-threatening arrhythmic events in patients with early PPCM, severely reduced left ventricular ejection fraction (LVEF) and symptoms of heart failure. Methods and results: Twelve consecutively admitted women with PPCM were included in this single-centre, prospective observational study between September 2012 and September 2013. Patients with LVEF ≤35% were considered to use the WCD for 3 months or even 6 months when considered necessary for LVEF recovery. Nine of the 12 women had a severely reduced LVEF (mean 18.3%) at the time of study enrolment; seven women received a WCD, while two patients refused to wear a WCD. During a median WCD follow-up of 81 days (range 25–345 days), we observed a total of four events of ventricular fibrillation with appropriate and successful WCD shocks in three of the seven women receiving a WCD. No syncope or sudden arrhythmic deaths occurred in women not using the WCD during a median follow-up of 12 months (range 5–15 months). All women showed impressive improvement of LVEF during follow-up. Conclusion: PPCM patients with severely reduced LVEF have an elevated risk for ventricular tachyarrhythmias early after diagnosis. Therefore, use of the WCD should be considered in all women with early-stage PPCM and severely reduced LVEF during the first 6 months after initiation of heart failure therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.188

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 158

Metadata

Authors
Duncker, D., Haghikia, A., König, T., Hohmann, S., Gutleben, K.-J., Westenfeld, R., Oswald, H., Klein, H., Bauersachs, J., Hilfiker-Kleiner, D., & Veltmann, C.
Venue
European Journal of Heart Failure
Published
2014-11-05
Volume
16
Issue
12
Pages
1331-1336
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2105000467
Cited by
158
References
2
FWCI
10.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk for Ventricular Fibrillation in Peripartum Cardiomyopathy with Severely Reduced Left Ventricular Function—Value of the Wearable Cardioverter/Defibrillator. https://app.cochat.ai/papers/10.1002/ejhf.188
The paper
Duncker, D., Haghikia, A., König, T., Hohmann, S., Gutleben, K.-J., Westenfeld, R., Oswald, H., Klein, H., Bauersachs, J., Hilfiker-Kleiner, D., & Veltmann, C. (2014). Risk for Ventricular Fibrillation in Peripartum Cardiomyopathy with Severely Reduced Left Ventricular Function—Value of the Wearable Cardioverter/Defibrillator. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.